Drug Trial Radar · NCT02386839
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
Last checked: Nov 20, 2026Latest source record: May 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
76
Actual
Start
Mar 26, 2015
Primary completion
Sep 28, 2021
Study completion Sep 28, 2021
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 12, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 weeks, up to 108 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the long-term efficacy and safety outcomes following short-term exposure to rhIGF-1/rhIGFBP-3 versus standard neonatal care in Study ROPP-2008-01 (NCT01096784).
Conditions
- Retinopathy of Prematurity (ROP)
Interventions
rhIGF-1/rhIGFBP-3Drug
Participants who received "rhIGF-1/rhIGFBP-3" in study ROPP-2008-01 (NCT01096784) will be enrolled to this study. No investigational product will be administered in this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 6 Months Corrected Age (CA)Time frame: At 6 Months CA
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 12 Months CATime frame: At 12 Months CA
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 20 Months CATime frame: At 20 Months CA
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 24 Months CATime frame: At 24 Months CA
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 4.75 Years CATime frame: At 4.75 Years CA
- Number of Participants With Visual Acuity as Assessed by an Age-appropriate Method at 5 Years CATime frame: At 5 Years CA
- Number of Participants With Oculomotor Examination (Motility) and Ocular Alignment (Assessed by Corneal Light Reflex and Cover Test) at 12 Months CATime frame: At 12 Months CA
- Number of Participants With Oculomotor Examination (Motility) and Ocular Alignment (Assessed by Corneal Light Reflex and Cover Test) at 24 Months CATime frame: At 24 Months CA
- Number of Participants With Oculomotor Examination (Motility) and Ocular Alignment (Assessed by Corneal Light Reflex and Cover Test) at 5-Years CATime frame: At 5 Years CA
- Number of Participants With Nystagmus at 12 Months CATime frame: At 12 Months CA
- Number of Participants With Nystagmus at 24 Months CATime frame: At 24 Months CA
- Number of Participants With Nystagmus at 5 Years CATime frame: At 5 Years CA
- Refraction With Cycloplegia as Assessed by Retinoscopy at 6 Months CATime frame: At 6 Months CA
- Refraction With Cycloplegia as Assessed by Retinoscopy at 12 Month CATime frame: At 12 Months CA
- Refraction With Cycloplegia as Assessed by Retinoscopy at 20 Month CATime frame: At 20 Months CA
- Refraction With Cycloplegia as Assessed by Retinoscopy at 4.75 Years CATime frame: At 4.75 Years CA
- Number of Participants With Stereoacuity as Assessed With the Lang Stereotest At 5 Years CATime frame: At 5 Years CA
- Number of Participants With Adverse Events (AEs)Time frame: From start of study up to end of study (up to 6.5 years)
Locations
16 sites in 6 countries. Site status is shown where the registry gives one.
University of South Alabama Children's and Women's Hospital
Mobile, Alabama
Vidant Medical Center
Greenville, North Carolina
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
University of Wisconsin - Madison
Madison, Wisconsin
Azienda Ospedaliera Universitaria Careggi
Florence, Italy
Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e
Genova, Italy
University of Padua
Padua, Italy
Policlinico Universitario Agostino Gemelli
Roma, Italy
VU Medical Center
Amsterdam, Netherlands
Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego w Poznan
Poznan, Poland
Skanes Universitetssjukhus Lund
Lund, Sweden
Karolinska Universitetssjukhuset Huddinge
Stockholm, Sweden
Addenbrookes Hospital
Cambridge, United Kingdom
St Peter's Hospital
Chertsey, United Kingdom
Alder Hey Childrens Hospital
Liverpool, United Kingdom
UCL EGA Institute for Women's Health
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.